Vanguard Capital Management
ANVS icon

Vanguard Capital Management’s Annovis Bio ANVS Stock Holding History

Vanguard Capital Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.06M Buy
1,647,322
+774,941
+89% +$1.51M ﹤0.01% 3288
2026
Q1 		$1.95M Buy
+872,381
New +$2.39M ﹤0.01% 3374

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Capital Management's ANVS Position: Q2 2026 in Review

Vanguard Capital Management increased its Annovis Bio (ANVS) stake by 89% in Q2 2026, buying an estimated $1.51M and bringing the position to 1,647,322 shares worth $3.06M. The position accounts for ﹤0.01% of the portfolio, ranked #3288.

Vanguard Capital Management first reported a position in ANVS in Q1 2026 and has held it in 2 quarters since. 60 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Vanguard Capital Management held 1,647,322 shares of Annovis Bio worth $3.06M as of Q2 2026.
  • Vanguard Capital Management bought 774,941 Annovis Bio shares in Q2 2026, an estimated $1.51M.
  • Annovis Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3288 holding.
  • Vanguard Capital Management first reported a position in Annovis Bio in Q1 2026 and has held it in 2 quarters since.
  • 60 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.